The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.73BCNY
1.45B · vs all stocks (USD)
Updated Sep 22, 2026
Revenue (TTM)
81.28MCNY
12.13M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
-119.08%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Beta
0.3620x
vs all stocks
Updated Sep 22, 2026
52-Week Change
29.28%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
9.73BCNY
1.45B · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
9.41BCNY
1.40B · vs all stocks (USD)
Updated Sep 22, 2026
Price to Book (MRQ)
32.29x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Enterprise to Revenue
115.73x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Gross Margin
45.44%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 5.38%.Updated Sep 22, 2026
Profit Margin
-119.08%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Operating Margin
-87.35%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Return on Assets (TTM)
-4.91%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Return on Equity (TTM)
-32.05%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Revenue (TTM)
81.28MCNY
12.13M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
1.16CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
-26.50%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Gross Profit (TTM)
4.37MCNY
652.94K · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
-37.30MCNY
-5.57M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
-96.78MCNY
-14.45M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
-26.46%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Operating Cash Flow (TTM)
19.14MCNY
2.86M · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
-47.92MCNY
-7.15M · vs all stocks (USD)
Updated Sep 22, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Minority Interest (Equity)
-23.82MCNYFY2025 · Dec 31, 2025
Revenue
99.39MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
64.11MCNYFY2025 · Dec 31, 2025
Gross Profit
35.29MCNYFY2025 · Dec 31, 2025
Operating Income
-33.04MCNY
-4.93M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-77.44MCNYFY2025 · Dec 31, 2025
Income Tax Expense
19.01MCNYFY2025 · Dec 31, 2025
Net Income
-96.45MCNYFY2025 · Dec 31, 2025
EBIT
-71.07MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-11.21MCNYFY2025 · Dec 31, 2025
Research & Development
17.41MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
20.40MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
2.61MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
265.68KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
6.37MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-1.35CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-1.35CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
70.22MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
70.22MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-96.45MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.65MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
26.62MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-2.46MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
53.36MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-96.45MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
6.44MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
52.71MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
63.92MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-29.07MCNYFY2025 · Dec 31, 2025
Net Acquisitions
17.65MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-10.50MCNYFY2025 · Dec 31, 2025
Sale of Investments
10.52MCNYFY2025 · Dec 31, 2025
Other Investing Activity
3.07MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-8.33MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
187.23MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-181.54MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-10.06MCNYFY2025 · Dec 31, 2025
Other Financing Charges
12.36MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
8.00MCNYFY2025 · Dec 31, 2025
Shares Outstanding
70.47MSharesUpdated Sep 22, 2026
Float Shares
32.17MSharesUpdated Sep 22, 2026
% Held by Insiders
44.22%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
13.31%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
90.99MCNY
13.58M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
1.29CNYUpdated Sep 22, 2026
Total Debt (MRQ)
344.60MCNY
51.44M · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
1.33x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Current Ratio (MRQ)
1.72x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Book Value per Share (MRQ)
4.03CNYUpdated Sep 22, 2026
Total Assets
714.62MCNY
106.67M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
218.48MCNYFY2025 · Dec 31, 2025
Total Liabilities
434.79MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
496.13MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
244.88MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
189.91MCNYFY2025 · Dec 31, 2025
Cash
53.36MCNYFY2025 · Dec 31, 2025
Cash Equivalents
6.19MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
59.54MCNYFY2025 · Dec 31, 2025
Accounts Receivable
63.14MCNYFY2025 · Dec 31, 2025
Inventory
74.21MCNYFY2025 · Dec 31, 2025
Accounts Payable
61.61MCNYFY2025 · Dec 31, 2025
Short-term Debt
94.10MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.74MCNYFY2025 · Dec 31, 2025
Long-term Debt
186.15MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
5.35MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
70.47MCNYFY2025 · Dec 31, 2025
Retained Earnings
-71.29MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
279.83MCNY
41.77M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
65.50CNYUpdated Sep 22, 2026
52-Week High
166.03CNYUpdated Sep 22, 2026
52-Week Change
29.28%
vs all stocks
Updated Sep 22, 2026
Beta
0.3620x
vs all stocks
Updated Sep 22, 2026
50-Day MA
103.34CNYUpdated Sep 22, 2026
200-Day MA
105.13CNYUpdated Sep 22, 2026
Avg 10-Day Volume
621.68KSharesUpdated Sep 22, 2026
Avg 30-Day Volume
525.73KSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
-1.38CNYUpdated Sep 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -87.4%, lower than 95% of its Scientific & Technical Instruments peers (median 13.4%)Significant